Clinical Trial Update: "HB-adMSCs for the Treatment of Patients With Multiple Sclerosis" [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating HB-adMSCs for Relapsing-Remitting Multiple Sclerosis and Multiple Sclerosis; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• HB-adMSCs (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Relapsing Remitting Multiple Sclerosis (RRMS), Multiple Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING